CAH Cardinal Health Inc

Cardinal Health Chairman Highlights Results, Looks to Future in Annual Meeting Address Board of Directors Declare First Quarter Dividend DUBLIN, Ohio, Nov. 5 /PRNewswire-FirstCall/ -- The chairman and chief executive officer of Cardinal Health , the leading provider of products and services supporting the health care industry, reported to shareholders today that the company is positioned "better than any time in its history" for growth in the $4 trillion global health care market. Robert D. Walter reviewed financial highlights and outlined future growth prospects at Cardinal Health's annual meeting of shareholders, held here today. The company's board of directors also declared today a regular quarterly dividend of $0.03 per common share, without par value. The dividend, which is the company's 77th consecutive regular quarterly dividend, is payable on January 15, 2004 to shareholders of record on January 1, 2004. "Cardinal Health has consistently delivered superior results in revenue growth, operating earnings, value creation and stock performance; however our greatest achievement has been to establish an essential role for the company in the chain of care," Walter said. "Today, the company is positioned better than any time in its history due to the breadth of products and services we provide, the value we can bring through integrated offerings and the focus we've placed on customer satisfaction. "The health care market continues to be a very attractive and growing market. Our goal is simply to make it easier for our customers to focus on what they do best: developing products or providing services that improve people's lives." Walter also said Cardinal Health will continue to invest in its growing business, citing the recent acquisition of Gala Biotech and last week's cash offer for Intercare, plc as examples. The company's strong cash flow and balance sheet will enable continued deployment of capital toward strategic acquisitions and investments that build scale, expand product and service offerings, or provide new technology to increase value for customers. Shareholders also re-elected five board members to three-year terms. Those board members are Dave Bing, chairman and CEO, The Bing Group, LLC; John F. Finn, chairman and CEO, Gardner, Inc.; John F. Havens, director emeritus and retired chairman, Bank One Corp.; David W. Raisbeck, vice chairman, Cargill, Inc; and Walter. About Cardinal Health Cardinal Health, Inc. ( http://www.cardinal.com/ ) is the leading provider of products and services supporting the health care industry. Cardinal Health develops, manufactures, packages and markets products for patient care; develops drug-delivery technologies; distributes pharmaceuticals, medical- surgical and laboratory supplies; and offers consulting and other services that improve quality and efficiency in health care. Headquartered in Dublin, Ohio, Cardinal Health employs more than 50,000 people on five continents and produces annual revenues of more than $50 billion. Cardinal Health is ranked #19 on the current Fortune 500 list and was named one of "The World's Best" companies by Forbes magazine in 2002. Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. The most significant of these uncertainties are described in Cardinal Health's Form 10-K, Form 8-K and Form 10-Q reports (including all amendments to those reports) and exhibits to those reports, and include (but are not limited to) the costs, difficulties, and uncertainties related to the integration of acquired businesses, the loss of one or more key customer or supplier relationships or changes to the terms of those relationships, changes in the distribution patterns or reimbursement rates for health-care products and/or services, the costs and other effects of governmental regulation and legal and administrative proceedings, and general economic and market conditions. Cardinal Health undertakes no obligation to update or revise any forward- looking statement. DATASOURCE: Cardinal Health, Inc. CONTACT: Media, Jim Mazzola, +1-614-757-3690, or email, , or Investors, Steve Fischbach, +1-614-757-7067, or email, Web site: http://www.cardinal.com/

Copyright